News
Cardano (ADA) Struggles Below $0.25 as Whales Accumulate Despite Price Weakness
56+ min ago (309+ words) Cardano (ADA) continues facing downward pressure throughout this week, remaining beneath the $0.25 threshold as wider cryptocurrency market turbulence impacts token valuations. An attempted rebound on Monday proved short-lived, with ADA subsequently retreating into negative price action. During Monday's session, ADA…...
Ethereum (ETH) Surges Past $2,100 as ETFs Attract $120M in Fresh Capital
1+ hour, 14+ min ago (611+ words) Ethereum has posted a robust gain exceeding 5% over the last day, successfully reclaiming the psychologically important $2,100 threshold that market participants have closely monitored. The upward momentum coincided with President Donald Trump issuing warnings to Iran regarding Strait of Hormuz access,…...
Ethereum (ETH) Surges Past $2,100 as ETFs Record $120 Million Daily Inflow
1+ hour, 14+ min ago (597+ words) Ethereum has registered a sharp 5%+ gain over the last 24 hours, successfully breaking back above the psychologically important $2,100 price point that market participants have been monitoring. The upward movement followed President Donald Trump's warning to Iran regarding Strait of Hormuz access,…...
Intel (INTC) Stock: Advanced Packaging Deals With Tech Giants Could Transform Foundry Business
14+ hour, 6+ min ago (334+ words) Shares of Intel (INTC) stock hovered near $20 on Monday as investors processed fresh reporting on the semiconductor giant's advanced packaging ambitions. According to Wired, which cited several industry sources, Intel has engaged in active discussions with Google (GOOGL) and Amazon…...
Nvidia (NVDA) Stock: Slides as AGI Hype Sparks $1 Trillion Growth Story
14+ hour, 44+ min ago (352+ words) NVIDIA (NVDA) shares traded near $176 during intraday action, reflecting a steady decline and weak rebound attempts. The stock showed persistent selling pressure, especially after a sharp mid-morning drop. The company projected up to $1 trillion in chip sales, driven by rising…...
Silo Pharma (SILO) Stock: Surges on Novel Stress Treatment Patent Progress
9+ hour, 58+ min ago (459+ words) Silo Pharma, Inc. (SILO) shares jumped sharply in after-hours trading, reaching $0.4979 after gaining 39.94%. The stock had earlier closed at $0.3558, up 2.95% during regular trading. The move followed a key European patent update tied to its stress-related treatment program. Silo Pharma, Inc.,…...
Three Energy Stocks to Watch: GE Vernova, Constellation, and NextEra Set Bold 2026 Targets
14+ hour, 8+ min ago (267+ words) Three prominent energy sector companies'GE Vernova, Constellation Energy, and NextEra Energy'have unveiled forward-looking guidance and strategic initiatives that have captured the attention of growth-oriented investors. While all three operate within the energy industry, they occupy distinct niches with varying business…...
ARK Invest Doubles Down on AI Infrastructure with CoreWeave and OpenAI Purchases
19+ hour, 56+ min ago (474+ words) Cathie Wood's investment firm ARK Invest demonstrated a decisive pivot toward artificial intelligence infrastructure, genomics innovation, and sustainable energy last week, deploying millions in fresh positions while scaling back several legacy holdings. The most substantial acquisition involved CoreWeave, an Nvidia-supported…...
JPMorgan Predicts 60% Plunge for Tesla (TSLA) Stock — Analysis and Details
14+ hour, 4+ min ago (435+ words) JPMorgan's Ryan Brinkman remains unconvinced about Tesla's turnaround prospects " and he's making his position crystal clear. On Monday, Brinkman reaffirmed his Sell recommendation on Tesla (TSLA), maintaining his $145 price objective. This target suggests potential downside of approximately 60% from the stock's…...
UnitedHealth (UNH) Stock Receives Outperform Rating from Raymond James Before Q1 Results
13+ hour, 36+ min ago (480+ words) UnitedHealth Group prepares to unveil its first-quarter financial performance on April 21, with market participants paying close attention following a challenging beginning to 2026. Shares have tumbled approximately 17% year-to-date, weighed down by disappointing forward guidance and persistent challenges within its Medicare Advantage…...